Cargando…

Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs

INTRODUCTION: Studies measuring the effectiveness of risk minimization measures (RMMs) submitted by pharmaceutical companies to the European Medicines Agency are part of the post-authorization regulatory requirements and represent an important source of data covering a range of medicinal products an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazzaglia, Giampiero, Straus, Sabine M. J., Arlett, Peter, da Silva, Daniela, Janssen, Heidi, Raine, June, Alteri, Enrica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808048/ https://www.ncbi.nlm.nih.gov/pubmed/29124666 http://dx.doi.org/10.1007/s40264-017-0604-4

Ejemplares similares

Improving the Safety of Medicines in the European Union: From Signals to Action
por: Potts, Joanne, et al.
Publicado: (2019)

The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines
por: Cavaleri, Marco, et al.
Publicado: (2021)

Promoting and Protecting Public Health: How the European Union Pharmacovigilance System Works
por: Santoro, Aniello, et al.
Publicado: (2017)

The European Medicines Agency's approval of new medicines for type 2 diabetes
por: Blind, Eberhard, et al.
Publicado: (2018)

Reporting of harms in oncological clinical study reports submitted to the European Medicines Agency compared to trial registries and publications—a methodological review
por: Paludan-Müller, Asger S., et al.
Publicado: (2021)

Review and comparison of clinical evidence submitted to support European Medicines Agency market authorization of orphan-designated oncological treatments
por: Winstone, Julie, et al.
Publicado: (2015)

Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation
por: Vatzaki, Efstratia, et al.
Publicado: (2018)

Perspectives of the European Society of Endocrinology (ESE) and the European Society of Paediatric Endocrinology (ESPE) on rare endocrine disease
por: Reincke, Martin, et al.
Publicado: (2021)

Redefining Risk Stratification and Endpoints for Clinical Trials in Kidney Transplantation: Rationale and Methodology of Proposals Submitted to the European Medicines Agency by the European Society for Organ Transplantation
por: Naesens, Maarten, et al.
Publicado: (2022)

Sex Proportionality in Pre-clinical and Clinical Trials: An Evaluation of 22 Marketing Authorization Application Dossiers Submitted to the European Medicines Agency
por: Dekker, Marieke J. H. J., et al.
Publicado: (2021)

Navigating stormy waters: 10 years of operation of the European Union Regulatory Network Incident Management Plan for Medicines for Human Use
por: Santoro, Aniello, et al.
Publicado: (2020)

Pharmacovigilance 2030: Invited Commentary for the January 2020 “Futures” Edition of Clinical Pharmacology and Therapeutics
por: Arlett, Peter, et al.
Publicado: (2019)

Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies
por: Spelsberg, Angela, et al.
Publicado: (2017)

Editorial: Insights in cardiovascular endocrinology: 2023
por: Santulli, Gaetano
Publicado: (2023)

OxyContin was submitted and justifiably approved by the agency as a 12-hour dosage form
por: Fudin, Jeffrey, et al.
Publicado: (2016)

EHPnet: European Chemicals Agency
por: Dooley, Erin E.
Publicado: (2008)

Congenital Hypothyroidism: A 2020–2021 Consensus Guidelines Update—An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology
por: van Trotsenburg, Paul, et al.
Publicado: (2021)

The Neuro-endocrinological Role of Microbial Glutamate and GABA Signaling
por: Mazzoli, Roberto, et al.
Publicado: (2016)

Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection
por: Pacurariu, Alexandra C., et al.
Publicado: (2015)

Potential roles of ROR-α in cardiovascular endocrinology
por: Laitinen, Saara, et al.
Publicado: (2003)

Editorial: Rising stars in cardiovascular endocrinology 2022
por: Lorenzo, Óscar
Publicado: (2023)

Financial regulations of the European Space Agency
por: European Space Agency. Paris. Administrative and Finance Committee
Publicado: (1999)

Data processing at the European Space Agency
por: Mazza, C
Publicado: (1982)

‘Use of antipsychotics in children and adolescents: a picture from the ARITMO population-based European cohort study’
por: Kaguelidou, Florentia, et al.
Publicado: (2020)

Long COVID Syndrome: Lesson Learned and Future Implications
por: Mazzaglia, Giampiero
Publicado: (2023)

Non-vitamin-K oral anticoagulants and laboratory testing: now and in the future: Views from a workshop at the European Medicines Agency (EMA)
por: Salmonson, Tomas, et al.
Publicado: (2017)

41st symposium of the European Space Agency
por: Macchetto, F Duccio
Publicado: (2010)

Psychopharmacology at the era of EMEA (European Medicines Agency)
por: Pestana, Luis Camara, et al.
Publicado: (2010)

International Symposium on the History of the European Space Agency
por: Harris, R A
Publicado: (1999)

A bacteriophage journey at the European Medicines Agency
por: Debarbieux, Laurent, et al.
Publicado: (2015)

Endocrinology
por: Hadley, Mac E.
Publicado: (1996)

Endocrinology /
por: Binkley, Sue Ann, 1944-
Publicado: (1995)

Endocrinology /
Publicado: (2001)

Endocrinology
Publicado: (2011)

Endocrinology
Publicado: (1995)

Endocrinology
Publicado: (1937)

Endocrinology in Pakistan: Transcending in care of endocrinological disorders
por: Raza, S. Abbas
Publicado: (2011)

Impact assessment of the European Clinical Trials Directive: a longitudinal, prospective, observational study analyzing patterns and trends in clinical drug trial applications submitted since 2001 to regulatory agencies in six EU countries
por: Hartmann, Markus
Publicado: (2012)

Cardiovascular Endocrinology: Evolving Concepts and Updated Epidemiology of Relevant Diseases
por: Varzideh, Fahimeh, et al.
Publicado: (2021)

Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies
por: Bloem, Lourens T., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_74gc476bd9rhdq2bbbf0nf01bo